HVH-2930, CAS [[3034605-72-3]]

Produktübersicht

• Artikelname: HVH-2930, CAS [[3034605-72-3]]
• Artikelnummer: MCE-HY-161781
• Hersteller Artikelnummer: HY-161781
• Alternativnummer: MCE-HY-161781-10MMX1ML,MCE-HY-161781-100MG,MCE-HY-161781-25MG,MCE-HY-161781-50MG,MCE-HY-161781-10MG,MCE-HY-161781-5MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

HVH-2930 is a HSP90 C-terminal domain inhibitor with high oral bioavailability. HVH-2930 downregulates HSP90 client proteins, inhibits the HER2 signaling pathway, induces apoptosis, and suppresses the proliferation of breast cancer cells. HVH-2930 inhibits the proliferation of tumors sensitive or resistant to Trastuzumab (HY-P9907). HVH-2930 is applicable to relevant research on breast cancer[1].

Produkteigenschaften

• Molekulargewicht: 488.62
• Reinheit: 96.54
• CAS Nummer: [3034605-72-3]
• Formel: C29H36N4O3
• Target-Kategorie: Akt,Apoptosis,EGFR,HSP,Survivin

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound1